Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Baxter
Healthtrust
Daiichi Sankyo
Mallinckrodt
Chubb
Farmers Insurance
Chinese Patent Office
Express Scripts
UBS

Generated: June 21, 2018

DrugPatentWatch Database Preview

Sulfamethoxazole; trimethoprim - Generic Drug Details

see a sample report or, see our see our flat-rate plans

« Back to Dashboard

What are the generic sources for sulfamethoxazole; trimethoprim and what is the scope of sulfamethoxazole; trimethoprim freedom to operate?

Sulfamethoxazole; trimethoprim
is the generic ingredient in twenty-two branded drugs marketed by Sun Pharm Inds Inc, Monarch Pharms, Abraxis Pharm, Bedford, Hospira, Mylan Labs Ltd, Teva Pharms Usa, Watson Labs, West-ward Pharms Int, Sun Pharm Industries, Ani Pharms Inc, Aurobindo Pharma, Hi Tech Pharma, Lannett Co Inc, Teva, Sti Pharma Llc, Usl Pharma, Alpharma Us Pharms, Naska, Novel Labs Inc, Amneal Pharms Ny, Chartwell Molecules, Fosun Pharma, Glenmark Generics, Heather, Interpharm, Martec Usa Llc, Mutual Pharm, Pliva, Roxane, Vista Pharms, Teva Pharms, Superpharm, and Shionogi, and is included in sixty-three NDAs. Additional information is available in the individual branded drug profile pages.

There are twenty-seven drug master file entries for sulfamethoxazole; trimethoprim. Sixty-nine suppliers are listed for this compound.
Summary for sulfamethoxazole; trimethoprim
Synonyms for sulfamethoxazole; trimethoprim
117385-88-3
37341-72-3
38916-35-7
4-amino-N-(5-methyl-1,2-oxazol-3-yl)benzenesulfonamide; 5-[(3,4,5-trimethoxyphenyl)methyl]pyrimidine-2,4-diamine
4-AMINO-N-(5-METHYL-3-ISOXAZOLYL)-BENZENESULFONAMIDE COMPOUND WITH 5-(3,4,5-TRIMETHOXYBENZYL)PYRIMIDINE-2,4-DIAMINE
4-amino-N-(5-methylisoxazol-3-yl)benzenesulfonamide; 5-[(3,4,5-trimethoxyphenyl)methyl]pyrimidine-2,4-diamine
50641-67-3
50808-41-8
52499-85-1
74711-00-5
8064-90-2
8064-91-3
8076-73-1
A 033
AC1L7D1P
AKOS030548395
Benzenesulfonamide, 4-amino-N-(5-methyl-3-isoxazolyl)- & 5-((3,4,5-trimethoxyphenyl)methyl)-2,4-pyrimidinediamine
Benzenesulfonamide, mixt. with 5-[(3,4,5-trimethoxyphenyl)methyl]-2,4- pyrimidinediamine
CHEBI:3770
CHEMBL58061
Co-Trimazole
Co-Trimoxazole (BAN)
Cotrim.L.U.T.
CTK4J2930
D00285
Epitope ID:141805
HE071457
LS-178642
NSC-618652
NSC618652
SCHEMBL870329
SMX / TMP
SMX-TMP
SMX/TMP
Sulfameth/TMP
Sulfameth/Trimeth
Sulfamethoxazol-trimethoprim
Sulfamethoxazole - trimethoprim mixt
Sulfamethoxazole - trimethoprim mixture
Sulfamethoxazole / TMP
Sulfamethoxazole / trimethoprim
SULFAMETHOXAZOLE AND TRIMETHOPRIM
SULFAMETHOXAZOLE AND TRIMETHOPRIM DOUBLE STRENGTH
SULFAMETHOXAZOLE AND TRIMETHOPRIM SINGLE STRENGTH
Sulfamethoxazole mixture with trimethoprim
Sulfamethoxazole Trimethoprim
Sulfamethoxazole-trimeth
Sulfamethoxazole-trimethoprim
SXT
TMP / SMX
TMP & SMX
TMP-SMX
TMP/SMX
Trimethoprim & Sulfamethoxazole
Trimethoprim and sulfamethoxazole
Trimethoprim and sulphamethoxazole
Trimethoprim-sulfamethoxazole
Trimethoprim-sulfamethoxazole combination
Trimethoprim, Sulfamethoxazole Drug Combination
TRIMETHOPRIM/SULFAMETHOXAZOLE
Trimethoprimsulfa
Trimforte
Trimosulfa
WZRJTRPJURQBRM-UHFFFAOYSA-N

US Patents and Regulatory Information for sulfamethoxazole; trimethoprim

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Mylan Labs Ltd SULFAMETHOXAZOLE AND TRIMETHOPRIM sulfamethoxazole; trimethoprim INJECTABLE;INJECTION 206607-001 Aug 30, 2017 AP RX No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Aurobindo Pharma SULFAMETHOXAZOLE AND TRIMETHOPRIM sulfamethoxazole; trimethoprim TABLET;ORAL 090624-002 Feb 16, 2010 AB RX No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Martec Usa Llc SULFAMETHOXAZOLE AND TRIMETHOPRIM sulfamethoxazole; trimethoprim TABLET;ORAL 072408-001 Dec 7, 1988 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Teva Pharms Usa SULFAMETHOXAZOLE AND TRIMETHOPRIM sulfamethoxazole; trimethoprim INJECTABLE;INJECTION 073303-001 Oct 31, 1991 AP RX No Yes ➤ Sign Up ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

see a sample report or, see our see our flat-rate plans

Expired US Patents for sulfamethoxazole; trimethoprim

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Sun Pharm Industries BACTRIM PEDIATRIC sulfamethoxazole; trimethoprim SUSPENSION;ORAL 017560-002 Approved Prior to Jan 1, 1982 ➤ Sign Up ➤ Sign Up
Sun Pharm Industries BACTRIM DS sulfamethoxazole; trimethoprim TABLET;ORAL 017377-002 Approved Prior to Jan 1, 1982 ➤ Sign Up ➤ Sign Up
Monarch Pharms SEPTRA sulfamethoxazole; trimethoprim TABLET;ORAL 017376-001 Approved Prior to Jan 1, 1982 ➤ Sign Up ➤ Sign Up
Sun Pharm Inds Inc BACTRIM sulfamethoxazole; trimethoprim INJECTABLE;INJECTION 018374-001 Approved Prior to Jan 1, 1982 ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

see a sample report or, see our see our flat-rate plans

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Dow
Cerilliant
Moodys
Medtronic
Healthtrust
McKinsey
Baxter
Chinese Patent Office
QuintilesIMS

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.